| Capital Markets Industry | Financials Sector | Mr. Sachin Patel CEO | CNSX Exchange | - ISIN |
| Canada Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Midori Carbon Inc. is a distinguished venture capital firm that has been operational since 1998. Based in North Vancouver, Canada, the company focuses on making early-stage investments in innovative and transformative sectors. Midori Carbon Inc. has carved a niche for itself by prioritizing investments in diverse areas such as plant medicine, technology, wellness, and genomics. Originally known as AJA Ventures Inc., the firm has evolved its identity to better align with its vision of fostering groundbreaking advancements in health and technology.
Midori Carbon Inc. specializes in identifying and investing in promising early-stage companies across various sectors. The firm's investment strategy is tailored to support innovators who are developing unique solutions and products that can have a significant impact on their respective industries.
The firm actively engages in funding startups that are pioneering research and development in the plant medicine realm. This includes companies that are exploring natural remedies and wellness solutions derived from plants, reflecting Midori Carbon Inc.'s commitment to holistic health approaches.
Midori Carbon Inc. invests in cutting-edge technology firms that are at the forefront of innovation. By supporting startups that are transforming industries through technology, the firm aims to foster advancements that drive economic growth and societal benefits.
The firm recognizes the growing importance of wellness and wellbeing in contemporary society. Investing in companies that provide wellness solutions, products, and services, Midori Carbon Inc. seeks to enhance the quality of life for individuals and communities.
Midori Carbon Inc. also actively invests in the genomics sector, supporting companies that utilize genetic research to create innovative health solutions. This investment focus emphasizes the firm's commitment to improving health outcomes through scientific advancement and technology.